PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsneuroblastoma
MeSH D009447 - neuroblastoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018241:Primitive neuroectodermal tumors peripheral
0 Companies
0 Drugs
Success rate
D009447: 
Neuroblastoma
61 Companies
12 Drugs
$
Success rate
D018304:Olfactory esthesioneuroblastoma
0 Companies
0 Drugs
Success rate
D018305:Ganglioneuroblastoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIsotretinoin Claravis  2003-04-11   
Doxorubicin Doxorubicin  1995-07-28   
Etoposide Etoposide  1994-02-10   
Doxorubicin Myocet (previously Myocet)  2000-07-13   
Cyclophosphamide Neosar  1993-04-29   
Etoposide Toposar  1995-02-27   
Vincristine Vincasar  1987-07-17   
Vincristine Vincristine  1999-09-01   
Cisplatin Cisplatin  2000-05-16   
Meitheal PharmaceuticalsDacarbazine Dacarbazine  1998-08-27   
Dactinomycin Dactinomycin  2020-11-13   
Melphalan Melphalan  2021-05-28   
Etoposide Etoposide  1996-07-24   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Doxorubicin Doxorubicin  2017-05-15   
Melphalan Melphalan  2017-12-08   
Isotretinoin Zenatane  2013-03-25   
IngenusMelphalan Melphalan  2020-02-18   
MylanIsotretinoin Amnesteem  2002-11-08   
Doxorubicin Doxorubicin  2011-10-28   
Etoposide Etoposide  2001-09-19   
Melphalan Melphalan  2009-06-09   
Cisplatin Cisplatin  2012-04-18   
RocheIsotretinoin Accutane  1982-05-07   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
BayerDacarbazine Dtic-dome  1982-01-01   
PfizerDoxorubicin Adriamycin  1991-01-30   
Doxorubicin Doxorubicin  1982-01-01   
Eli LillyVincristine Oncovin  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
70%
87/124
Phase 2
27%
37/136
Phase 3
41%
25/61
Approved: 14Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cisplatin,
Cyclophosphamide,
Doxorubicin,
Doxorubicin hydrochloride,
Etoposide,
Vincristine,
Vincristine sulfate
Dr Reddys Laboratories
Doxorubicin,
Doxorubicin hydrochloride,
Isotretinoin
Roche
Isotretinoin,
Idasanutlin,
Lornoxicam,
Aspartame,
Bevifimod,
Vp16,
Abt199
Bayer
Dacarbazine,
Lornoxicam,
Sodium chloride,
BIMIRALISIB,
Bay806946
Pfizer
Doxorubicin,
Doxorubicin hydrochloride,
Tbo-filgrastim,
Lenograstim,
Lornoxicam,
Bevifimod,
Pd0332991
Eli Lilly
Vincristine sulfate,
Vincristine,
Cilmostim,
Regramostim,
Lornoxicam,
Molgramostim,
Polyglycolic acid,
Sagramostim,
LY3295668
Sun Pharmaceutical Industries
Isotretinoin
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use